Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing
Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration
Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295